Year |
Citation |
Score |
2020 |
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Maria Piraccini B. Onychomycosis: a review. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 32239567 DOI: 10.1111/Jdv.16394 |
0.327 |
|
2020 |
Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bellón T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, ... ... Shear NH, et al. SJS/TEN 2019: From science to translation. Journal of Dermatological Science. PMID 32192826 DOI: 10.1016/J.Jdermsci.2020.02.003 |
0.302 |
|
2020 |
Shavit E, Shear NH. An update on the safety of apremilast for the treatment of plaque psoriasis. Expert Opinion On Drug Safety. 1-6. PMID 32182143 DOI: 10.1080/14740338.2020.1744562 |
0.361 |
|
2019 |
Gupta AK, Stec N, Bamimore MA, Foley KA, Shear NH, Piguet V. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 31746067 DOI: 10.1111/Jdv.16101 |
0.337 |
|
2019 |
Chan FL, Shear NH, Shah N, Olteanu C, Hashimoto R, Dodiuk-Gad RP. New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019. Drug Safety. PMID 31673951 DOI: 10.1007/S40264-019-00880-9 |
0.306 |
|
2019 |
Khan DA, Knowles SR, Shear NH. Sulfonamide Hypersensitivity: Fact and Fiction. The Journal of Allergy and Clinical Immunology. in Practice. 7: 2116-2123. PMID 31495421 DOI: 10.1016/J.Jaip.2019.05.034 |
0.339 |
|
2019 |
Kinoshita-Ise M, Shear NH. Diagnostic and therapeutic approach to scalp dysesthesia: A case series and published work review. The Journal of Dermatology. PMID 31106878 DOI: 10.1111/1346-8138.14901 |
0.304 |
|
2019 |
Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI. Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome. World Journal of Clinical Cases. 7: 705-716. PMID 30968035 DOI: 10.12998/Wjcc.V7.I6.705 |
0.312 |
|
2019 |
Goldman JL, Chung WH, Lee BR, Chen CB, Lu CW, Hoetzenecker W, Micheletti R, Yasuda SU, Mariolis DJ, Shear NH, Struewing JP, Pirmohamed M. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. European Journal of Clinical Pharmacology. PMID 30918988 DOI: 10.1007/S00228-019-02670-9 |
0.325 |
|
2019 |
Fahim C, Kim BW, Bourcier M, Glassman S, Gooderham M, Guenther L, Gulliver W, Lynde C, Poulin Y, Pratt M, Shear N, Vender R, Walsh S, Fahim S. Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study. Journal of Cutaneous Medicine and Surgery. 1203475419833605. PMID 30854878 DOI: 10.1177/1203475419833605 |
0.31 |
|
2019 |
Martínez-Cabriales SA, Rodríguez-Bolaños F, Shear NH. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come? American Journal of Clinical Dermatology. PMID 30652265 DOI: 10.1007/S40257-018-00416-4 |
0.352 |
|
2019 |
Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V, Piraccini BM. Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review. Clinical Drug Investigation. PMID 30652260 DOI: 10.1007/S40261-018-00743-8 |
0.321 |
|
2019 |
Bewley AP, Shear NH, Calzavara‐Pinton PG, Hansen JB, Nyeland ME, Signorovitch J. Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison Journal of the European Academy of Dermatology and Venereology. 33: 1107-1115. PMID 30472749 DOI: 10.1111/Jdv.15369 |
0.35 |
|
2018 |
Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A. Global perspectives for the management of onychomycosis. International Journal of Dermatology. PMID 30585300 DOI: 10.1111/Ijd.14346 |
0.301 |
|
2018 |
Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, Lehloenya R, Mockenhaupt M, Peter J, Pirmohamed M, Roujeau JC, Shear NH, Tanno LK, Trubiano J, Valluzzi R, et al. Controversies in drug allergy: Testing for delayed reactions. The Journal of Allergy and Clinical Immunology. PMID 30573342 DOI: 10.1016/J.Jaci.2018.10.030 |
0.33 |
|
2018 |
Gupta AK, Versteeg SG, Shear NH, Piguet V, Tosti A, Piraccini BM. A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level. American Journal of Clinical Dermatology. PMID 30456537 DOI: 10.1007/S40257-018-0403-4 |
0.338 |
|
2018 |
Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Review of Anti-Infective Therapy. PMID 30411650 DOI: 10.1080/14787210.2018.1544891 |
0.318 |
|
2018 |
Singh S, Kalb RE, de Jong EMGJ, Shear NH, Lebwohl M, Langholff W, Hopkins L, Srivastava B, Armstrong AW. Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). American Journal of Clinical Dermatology. PMID 30267377 DOI: 10.1007/S40257-018-0388-Z |
0.302 |
|
2018 |
Ighani A, Georgakopoulos JR, Shear NH, Walsh S, Yeung J. Long-term 52-week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series. The British Journal of Dermatology. PMID 30120892 DOI: 10.1111/Bjd.17099 |
0.308 |
|
2018 |
Gupta AK, Versteeg SG, Shear NH. A Practical Application of Onychomycosis Cure - Combining Patient, Physician and Regulatory Body Perspectives. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 30005134 DOI: 10.1111/Jdv.15181 |
0.304 |
|
2018 |
Shah N, Alhusayen R, Walsh S, Shear NH. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study. Journal of Cutaneous Medicine and Surgery. 1203475418781336. PMID 29855201 DOI: 10.1177/1203475418781336 |
0.324 |
|
2018 |
Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 29797431 DOI: 10.1111/Jdv.15081 |
0.305 |
|
2018 |
Ighani A, Georgakopoulos JR, Shear NH, Walsh S, Yeung J. Maintenance of therapeutic response over one year using apremilast combination therapy compared to monotherapy for the treatment of plaque psoriasis: a multicenter, retrospective study. Journal of the American Academy of Dermatology. PMID 29730366 DOI: 10.1016/J.Jaad.2018.04.043 |
0.311 |
|
2018 |
Gupta AK, Versteeg SG, Shear NH. Common Drug-Drug Interactions in Antifungal Treatments for Superficial Fungal Infections. Expert Opinion On Drug Metabolism & Toxicology. PMID 29633864 DOI: 10.1080/17425255.2018.1461834 |
0.316 |
|
2018 |
Ighani A, Georgakopoulos JR, Zhou LL, Walsh S, Shear N, Yeung J. Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study. Journal of Cutaneous Medicine and Surgery. 1203475418755982. PMID 29373924 DOI: 10.1177/1203475418755982 |
0.319 |
|
2017 |
Mereniuk A, Jaque A, Jeschke MG, Shear NH. Toxic Epidermal Necrolysis Spectrum Management at Sunnybrook Health Sciences Centre: Our Multidisciplinary Approach After Review of the Current Evidence. Journal of Cutaneous Medicine and Surgery. 1203475417746148. PMID 29202605 DOI: 10.1177/1203475417746148 |
0.332 |
|
2017 |
Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, ... ... Shear NH, et al. Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Clinical Pharmacology and Therapeutics. PMID 29105735 DOI: 10.1002/Cpt.890 |
0.315 |
|
2017 |
Young JWS, Shear NH. Cutaneous Drug Reactions in the Elderly. Drugs & Aging. PMID 28801750 DOI: 10.1007/S40266-017-0483-5 |
0.319 |
|
2017 |
Segaert S, Shear NH, Chiricozzi A, Thaçi D, Carrascosa JM, Young H, Descamps V. Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy. Dermatology and Therapy. PMID 28785924 DOI: 10.1007/S13555-017-0196-Z |
0.321 |
|
2017 |
Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. Journal of Cutaneous Medicine and Surgery. 1203475417716362. PMID 28639462 DOI: 10.1177/1203475417716362 |
0.308 |
|
2017 |
Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-Induced Pyoderma Gangrenosum: A Review. American Journal of Clinical Dermatology. PMID 28624960 DOI: 10.1007/S40257-017-0308-7 |
0.327 |
|
2017 |
Shear NH, Alhusayen R, Fernandez-Obregon A, Kimball AB, Menter A, Wu JJ, Goyal K, Patel H, Lin R, Armstrong AW. Observations from our evaluation of body weight changes after initiation of a biologic therapy in PSOLAR. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 28622413 DOI: 10.1111/Jdv.14414 |
0.305 |
|
2017 |
AbuHilal M, Walsh S, Shear N. Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast. Journal of Dermatological Case Reports. 10: 56-57. PMID 28400896 DOI: 10.3315/Jdcr.2016.1232 |
0.311 |
|
2017 |
Wright G, McCormack M, Amstutz U, Shear N, Gamberdella A, Sills G, Rener-Premec Z, Lerche H, Kunz W, Depondt C, Zara F, Striano P, Delanty N, Ingason A, Diehl S, et al. A Genome-wide Analysis of Severe Cutaneous Adverse Drug Reactions to Anti-epileptic Drugs Journal of Pharmacological and Toxicological Methods. 88: 178. DOI: 10.1016/J.Vascn.2017.09.034 |
0.302 |
|
2016 |
Tan MG, Shear NH, Walsh S, Alhusayen R. Acitretin: Monotherapy or Combined Therapy for Hidradenitis Suppurativa? Journal of Cutaneous Medicine and Surgery. PMID 27432818 DOI: 10.1177/1203475416659858 |
0.32 |
|
2016 |
AbuHilal M, Walsh S, Shear N. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study Journal of Cutaneous Medicine and Surgery. 20: 313-316. PMID 26848145 DOI: 10.1177/1203475416631328 |
0.335 |
|
2016 |
Dodiuk-Gad RP, Olteanu C, Chung WH, Shear NH. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015. Drug Safety. PMID 26798049 DOI: 10.1007/S40264-015-0390-9 |
0.303 |
|
2015 |
Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update. American Journal of Clinical Dermatology. PMID 26481651 DOI: 10.1007/S40257-015-0158-0 |
0.345 |
|
2015 |
Alhusayen R, Shear NH. Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology. 73: S42-6. PMID 26470615 DOI: 10.1016/J.Jaad.2015.07.049 |
0.303 |
|
2015 |
Dodiuk-Gad RP, Shear NH. Granulomatous Drug Eruptions. Dermatologic Clinics. 33: 525-39. PMID 26143430 DOI: 10.1016/J.Det.2015.03.015 |
0.319 |
|
2015 |
Dodiuk-Gad RP, Ish-Shalom S, Shear NH. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist. International Journal of Dermatology. 54: 723-9. PMID 25683616 DOI: 10.1111/Ijd.12642 |
0.312 |
|
2014 |
Dodiuk-Gad RP, Laws PM, Shear NH. Epidemiology of severe drug hypersensitivity. Seminars in Cutaneous Medicine and Surgery. 33: 2-9. PMID 25037253 DOI: 10.12788/J.Sder.0057 |
0.347 |
|
2014 |
Laws PM, Kingston TP, Walsh S, Shear NH. Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients. Journal of Cutaneous Medicine and Surgery. 18: 287-90. PMID 25008449 DOI: 10.2310/7750.2013.13149 |
0.309 |
|
2014 |
Laws PM, Shear NH, Pope E. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy. Pediatric Dermatology. 31: 459-64. PMID 24916067 DOI: 10.1111/Pde.12338 |
0.306 |
|
2014 |
Dodiuk-Gad RP, Chung WH, Yang CH, Lu CW, Hui RC, Shear NH. The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions. Drug Safety. 37: 459-64. PMID 24788802 DOI: 10.1007/S40264-014-0165-8 |
0.321 |
|
2014 |
Shear NH, Hartmann M, Toledo-Bahena M, Katsambas A, Connors L, Chang Q, Yao R, Nograles K, Popmihajlov Z. Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice. The British Journal of Dermatology. 171: 631-41. PMID 24673357 DOI: 10.1111/Bjd.13004 |
0.328 |
|
2014 |
Heelan K, Al-Mohammedi F, Smith MJ, Knowles S, Lansang P, Walsh S, Shear NH. Durable remission of pemphigus with a fixed-dose rituximab protocol. Jama Dermatology. 150: 703-8. PMID 24500264 DOI: 10.1001/Jamadermatol.2013.6739 |
0.328 |
|
2014 |
Bergman H, Walton T, Del Bel R, Seki JT, Xu W, Koren G, Shear N, Krzyzanowska MK, Howell D, Liu G. Early intervention of skin toxicities by panitumumab and clinical outcomes in the clinical setting. Journal of Clinical Oncology. 32: e20673-e20673. DOI: 10.1200/Jco.2014.32.15_Suppl.E20673 |
0.322 |
|
2013 |
Heelan K, Ryan JF, Shear NH, Egan CA. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. Journal of Dermatological Case Reports. 7: 113-20. PMID 24421864 DOI: 10.3315/Jdcr.2013.1157 |
0.303 |
|
2013 |
Heelan K, Shear NH. Cutaneous drug reactions in children: an update. Paediatric Drugs. 15: 493-503. PMID 23842849 DOI: 10.1007/S40272-013-0039-Z |
0.333 |
|
2013 |
Shear NH, Frcpc. Dapsone DRESS and Genes That Fit Nejm Journal Watch. 2013. DOI: 10.1056/Nejm-Jw.Na32478 |
0.329 |
|
2012 |
Alavi A, Lowe J, Walsh S, Juurlink D, Mortaz-Hedjri S, Shear NH. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus. International Journal of Dermatology. 51: 1248-52. PMID 22994671 DOI: 10.1111/J.1365-4632.2012.05470.X |
0.306 |
|
2012 |
Drucker AM, Baibergenova A, Rosen CF, Shear NH. Narrowband UVB as an effective substitute for psoralen plus UVA: lessons from a psoralen shortage. Photodermatology, Photoimmunology & Photomedicine. 28: 267-8. PMID 22971194 DOI: 10.1111/J.1600-0781.2012.00683.X |
0.302 |
|
2012 |
Knowles SR, Dewhurst N, Shear NH. Anticonvulsant hypersensitivity syndrome: An update Expert Opinion On Drug Safety. 11: 767-778. PMID 22794330 DOI: 10.1517/14740338.2012.705828 |
0.331 |
|
2012 |
Matsukura S, Knowles SR, Walsh S, Shear NH. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: A case series of 9 patients Archives of Dermatology. 148: 734-739. PMID 22351790 DOI: 10.1001/Archdermatol.2011.3320 |
0.33 |
|
2011 |
Pirmohamed M, Friedmann PS, Molokhia M, Loke YK, Smith C, Phillips E, La Grenade L, Carleton B, Papaluca-Amati M, Demoly P, Shear NH. Phenotype standardization for immune-mediated drug-induced skin injury. Clinical Pharmacology and Therapeutics. 89: 896-901. PMID 21562486 DOI: 10.1038/Clpt.2011.79 |
0.329 |
|
2011 |
Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. American Journal of Clinical Dermatology. 12: 171-80. PMID 21469762 DOI: 10.2165/11539080-000000000-00000 |
0.308 |
|
2010 |
Elzagallaai AA, Jahedmotlagh Z, Del Pozzo-Magaa BR, Knowles SR, Prasad AN, Shear NH, Rieder MJ, Koren G. Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome Molecular Diagnosis and Therapy. 14: 317-322. PMID 21053997 DOI: 10.1007/Bf03256387 |
0.329 |
|
2009 |
Wexler D, Searles G, Landells I, Shear NH, Bissonnette R, Papp K, Poulin Y, Langley R, Gulliver WP. Update on alefacept safety. Journal of Cutaneous Medicine and Surgery. 13: S139-47. PMID 20053326 DOI: 10.2310/7750.2009.00032 |
0.322 |
|
2009 |
Searles G, Bissonnette R, Landells I, Shear NH, Papp K, Lui H. Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study. Journal of Cutaneous Medicine and Surgery. 13: S131-8. PMID 20053325 DOI: 10.2310/7750.2009.00031 |
0.321 |
|
2009 |
Landells I, Searles G, Bissonnette R, Shear NH, Vender R, Lui H. Efficacy outcomes in patients using alefacept in the AWARE study. Journal of Cutaneous Medicine and Surgery. 13: S122-30. PMID 20053324 DOI: 10.2310/7750.2009.00030 |
0.317 |
|
2009 |
Knowles S, Shear NH. Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatologic Therapy. 22: 441-51. PMID 19845721 DOI: 10.1111/J.1529-8019.2009.01260.X |
0.335 |
|
2009 |
Elzagallaai AA, Knowles SR, Rieder MJ, Bend JR, Shear NH, Koren G. In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: A systematic review Molecular Diagnosis and Therapy. 13: 313-330. PMID 19791835 DOI: 10.1007/Bf03256336 |
0.3 |
|
2009 |
Elzagallaai AA, Knowles SR, Rieder MJ, Bend JR, Shear NH, Koren G. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: A systematic review Drug Safety. 32: 391-408. PMID 19419234 DOI: 10.2165/00002018-200932050-00003 |
0.317 |
|
2008 |
Gollnick HPM, Finlay AY, Shear N. Can we define acne as a chronic disease? If so, how and when? American Journal of Clinical Dermatology. 9: 279-284. PMID 18717602 DOI: 10.2165/00128071-200809050-00001 |
0.331 |
|
2008 |
Shear NH, Milpied B, Bruynzeel DP, Phillips EJ. A review of drug patch testing and implications for HIV clinicians. Aids (London, England). 22: 999-1007. PMID 18520343 DOI: 10.1097/Qad.0B013E3282F7Cb60 |
0.327 |
|
2008 |
Piliotis E, Govas P, Imrie KR, Cheung MC, Shear N, Walsh S, Fairlie C, Barth D. Sezary Syndrome and Combination Immunomodulatory Therapy: Improving Clinical Outcomes Blood. 112: 4957-4957. DOI: 10.1182/Blood.V112.11.4957.4957 |
0.315 |
|
2007 |
Papp KA, Keystone EC, Shear NH. Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology: Journal of Cutaneous Medicine and Surgery. 11. DOI: 10.2310/7750.2006.00069 |
0.303 |
|
2006 |
Mittmann N, Chan B, Knowles S, Cosentino L, Shear N. Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome American Journal of Clinical Dermatology. 7: 359-368. PMID 17173470 DOI: 10.2165/00128071-200607060-00004 |
0.304 |
|
2006 |
Lowe DO, Knowles SR, Weber EA, Railton CJ, Shear NH. Povidone-iodine-induced burn: case report and review of the literature. Pharmacotherapy. 26: 1641-5. PMID 17064209 DOI: 10.1592/Phco.26.11.1641 |
0.328 |
|
2006 |
Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches. Journal of Cutaneous Medicine and Surgery. 9: 18-25. PMID 16633860 DOI: 10.1007/S10227-006-0103-1 |
0.352 |
|
2006 |
Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis. Journal of Cutaneous Medicine and Surgery. 9: 26-32. PMID 16633859 DOI: 10.1007/S10227-006-0104-0 |
0.355 |
|
2006 |
Shear NH. Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability? Drug Safety. 29: 49-66. PMID 16454534 DOI: 10.2165/00002018-200629010-00004 |
0.325 |
|
2005 |
Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH. Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis. 53: 335-8. PMID 16364122 DOI: 10.1111/J.0105-1873.2005.00716.X |
0.326 |
|
2005 |
Knowles SR, Wong GA, Rahim SA, Binkley K, Phillips EJ, Shear NH. Hydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction. Pharmacotherapy. 25: 1258-65. PMID 16164399 DOI: 10.1592/Phco.2005.25.9.1258 |
0.333 |
|
2005 |
Wong GA, Shear NH. Adverse drug interactions and reactions in dermatology: current issues of clinical relevance. Dermatologic Clinics. 23: 335-42. PMID 15837159 DOI: 10.1016/J.Det.2004.08.001 |
0.305 |
|
2005 |
Shear NH, Frcpc. Factors of TEN Nejm Journal Watch. 2005. DOI: 10.1056/Jd200507260000002 |
0.302 |
|
2005 |
Iskedjian M, Barkovsky L, Desjardins O, Walker J, Dorkalam M, Shear N, Einarson T. Psk5 Cost-Utility Analysis Of Amevive Tm (Alefacept) In The Treatment Of Patients With Moderate-To-Severe Psoriasis Value in Health. 8: 331. DOI: 10.1016/S1098-3015(10)62869-0 |
0.31 |
|
2005 |
Iskedjian M, Barkovsky L, Desjardins O, Walker J, Dorkalam M, Shear N, Einarson T. Psk1 Cost-Effectiveness Analysis Of Amevive Tm (Alefacept) In The Treatment Of Patients With Moderate-To-Severe Psoriasis Value in Health. 8: 330. DOI: 10.1016/S1098-3015(10)62865-3 |
0.312 |
|
2004 |
Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004. Journal of Cutaneous Medicine and Surgery. 8: 321-37. PMID 15868311 DOI: 10.1007/S10227-005-0035-1 |
0.316 |
|
2004 |
Knowles SR, Phillips EJ, Wong G, Shear NH. Serious dermatologic reaction associated with valdecoxib: report of two cases. Journal of the American Academy of Dermatology. 51: 1028-9. PMID 15583610 DOI: 10.1016/J.Jaad.2004.08.013 |
0.329 |
|
2004 |
Mittmann N, Knowles SR, Gomez M, Fish JS, Cartotto R, Shear NH. Evaluation of the extent of under-reporting of serious adverse drug reactions: The case of toxic epidermal necrolysis Drug Safety. 27: 477-487. PMID 15141997 DOI: 10.2165/00002018-200427070-00004 |
0.328 |
|
2004 |
Koren G, Avner M, Shear N. Generic isotretinoin: a new risk for unborn children. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 170: 1567-8. PMID 15136551 DOI: 10.1503/Cmaj.1040317 |
0.33 |
|
2004 |
Shear NH, Frcpc. IVIg to Prevent SJS Nejm Journal Watch. 2004. DOI: 10.1056/Jd200403030000003 |
0.309 |
|
2003 |
Knowles SR, Shapiro LE, Shear NH. Reactive metabolites and adverse drug reactions: clinical considerations. Clinical Reviews in Allergy & Immunology. 24: 229-38. PMID 12721394 DOI: 10.1385/Criai:24:3:229 |
0.334 |
|
2003 |
Mandelcorn R, Shear NH. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? Journal of the American Academy of Dermatology. 48: 525-9. PMID 12664014 DOI: 10.1067/Mjd.2003.107 |
0.317 |
|
2003 |
Notman MJ, Knowles SR, Phillips EJ, Weber EA, Shear NH. Ciprofloxacin skin testing: A retrospective study The Journal of Allergy and Clinical Immunology. 111. DOI: 10.1016/S0091-6749(03)80558-4 |
0.309 |
|
2002 |
Neuman MG, Malkiewicz IM, Phillips EJ, Rachlis AR, Ong D, Yeung E, Shear NH. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Therapeutic Drug Monitoring. 24: 728-36. PMID 12451289 DOI: 10.1097/00007691-200212000-00008 |
0.315 |
|
2002 |
Shapiro LE, Shear NH. Drug interactions: Proteins, pumps, and P-450s. Journal of the American Academy of Dermatology. 47: 467-84; quiz 485-8. PMID 12271287 DOI: 10.1067/Mjd.2002.126823 |
0.302 |
|
2002 |
Sullivan JR, Shear NH. Drug eruptions and other adverse drug effects in aged skin. Clinics in Geriatric Medicine. 18: 21-42. PMID 11913737 DOI: 10.1016/S0749-0690(03)00032-6 |
0.341 |
|
2002 |
Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3·0% diclofenac in 2·5% hyaluronan gel British Journal of Dermatology. 146: 94-100. PMID 11841372 DOI: 10.1046/J.1365-2133.2002.04561.X |
0.302 |
|
2002 |
Shear NH, Frcpc. Skin Testing for Drug Reactions -- Guidelines Are a Start Nejm Journal Watch. 2002. DOI: 10.1056/Jd200203120000004 |
0.309 |
|
2001 |
Lowitt MH, Shear NH. Pharmacogenomics and dermatological therapeutics. Archives of Dermatology. 137: 1512-1514. PMID 11708958 DOI: 10.1001/Archderm.137.11.1512 |
0.306 |
|
2001 |
Ozdemir V, Shear NH, Kalow W. What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects Drug Safety. 24: 75-85. PMID 11235820 DOI: 10.2165/00002018-200124020-00001 |
0.332 |
|
2000 |
Neuman MG, Malkiewicz IM, Shear NH. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Clinical Biochemistry. 33: 517-524. PMID 11124336 DOI: 10.1016/S0009-9120(00)00146-6 |
0.305 |
|
2000 |
Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet (London, England). 356: 1587-91. PMID 11075787 DOI: 10.1016/S0140-6736(00)03137-8 |
0.315 |
|
2000 |
Sullivan JR, Shear NH. What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions? The British Journal of Dermatology. 142: 205-7. PMID 10730749 DOI: 10.1046/J.1365-2133.2000.03341.X |
0.311 |
|
2000 |
Gupta A, Maddin S, Arlette J, Giroux J, Shear N. Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study Journal of Dermatological Treatment. 11: 33-37. DOI: 10.1080/09546630050517658 |
0.312 |
|
2000 |
Trakas K, Oh P, Shear N. Pwp4: A Willingness-To-Pay Assessment Of Two Treatments For Obesity Value in Health. 3: 116. DOI: 10.1016/S1098-3015(11)70490-9 |
0.737 |
|
1999 |
Gupta AK, Katz HI, Shear NH. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. Journal of the American Academy of Dermatology. 41: 237-249. PMID 10426895 DOI: 10.1016/S0190-9622(99)70055-1 |
0.307 |
|
1998 |
Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions Journal of Clinical Pharmacology. 38: 1003-1009. PMID 9824780 DOI: 10.1177/009127009803801103 |
0.34 |
|
1998 |
Schlienger RG, Oh PI, Knowles SR, Shear NH. Quantifying the Costs of Serious Adverse Drug Reactions to Antiepileptic Drugs Epilepsia. 39. PMID 9798759 DOI: 10.1111/J.1528-1157.1998.Tb01682.X |
0.331 |
|
1998 |
Schlienger RG, Shapiro LE, Shear NH. Lamotrighe‐Induced Severe Cutaneous Adverse Reactions Epilepsia. 39. PMID 9798758 DOI: 10.1111/J.1528-1157.1998.Tb01681.X |
0.338 |
|
1998 |
Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia. 39. PMID 9798755 DOI: 10.1111/J.1528-1157.1998.Tb01678.X |
0.33 |
|
1998 |
Lester RS, Knowles SR, Shear NH. The Risks Of Systemic Corticosteroid Use Dermatologic Clinics. 16: 277-288. PMID 9589201 DOI: 10.1016/S0733-8635(05)70010-3 |
0.319 |
|
1998 |
Trakas K, Oh P, Einarson T, Shear N. PGD14 A Health Economic Analysis of Fluticasone Propionate, Budesonide, And Beclomethasone Dipropionate for the Treatment of Moderate to Severe Asthma Value in Health. 1: 62-62. DOI: 10.1046/J.1524-4733.1998.11005714.X |
0.751 |
|
1997 |
Gupta AK, Shear NH. Terbinafine: An update Journal of the American Academy of Dermatology. 37: 979-988. PMID 9418768 DOI: 10.1016/S0190-9622(97)70076-8 |
0.308 |
|
1997 |
Knowles S, Shapiro L, Shear NH. Serious dermatologic reactions in children. Current Opinion in Pediatrics. 9: 388-395. PMID 9300197 DOI: 10.1097/00008480-199708000-00014 |
0.306 |
|
1997 |
Gupta AK, Sibbald RG, Knowles SR, Lynde CW, Shear NH. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: Four case reports and a review of drug-induced psoriasis☆☆☆★ Journal of the American Academy of Dermatology. 36: 858-862. PMID 9146568 DOI: 10.1016/S0190-9622(97)70041-0 |
0.332 |
|
1997 |
Einarson TR, Oh PI, Gupta AK, Shear NH. Multinational pharmacoeconomic analysis of topical and oral therapies for onychomycosis Journal of Dermatological Treatment. 8: 229-235. DOI: 10.3109/09546639709160527 |
0.324 |
|
1997 |
Mittmann N, Liu BA, Iskedjian M, Bradley CA, Pless R, Shear NH, Einarson TR. Drug-related mortality in Canada (1984-1994) Pharmacoepidemiology and Drug Safety. 6: 157-168. DOI: 10.1002/(Sici)1099-1557(199705)6:3<157::Aid-Pds260>3.0.Co;2-J |
0.318 |
|
1997 |
Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline Archives of Dermatology. 133: 1224-1230. DOI: 10.1001/Archderm.1997.03890460044005 |
0.353 |
|
1996 |
Shapiro LE, Shear NH. Mechanisms of drug reactions: the metabolic track. Seminars in Cutaneous Medicine and Surgery. 15: 217-227. PMID 9069589 DOI: 10.1016/S1085-5629(96)80034-4 |
0.33 |
|
1996 |
Shear NH, Knowles SR, Shapiro L, Poldre P. Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis Journal of the American Academy of Dermatology. 35: 819-822. PMID 8912594 DOI: 10.1016/S0190-9622(96)90092-4 |
0.307 |
|
1996 |
Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clinical Therapeutics. 18: 160-182. PMID 8851461 DOI: 10.1016/S0149-2918(96)80188-3 |
0.303 |
|
1996 |
Prussick R, Shear NH. Dapsone hypersensitivity syndrome Journal of the American Academy of Dermatology. 35: 346-349. PMID 8698924 DOI: 10.1016/S0190-9622(96)90667-2 |
0.329 |
|
1996 |
Knowles SR, Shapiro L, Shear NH. Serious Adverse Reactions Induced by Minocycline: Report of 13 Patients and Review of the Literature Archives of Dermatology. 132: 934-939. DOI: 10.1001/Archderm.1996.03890320082013 |
0.344 |
|
1996 |
Gupta AK, Gonder JR, Shear NH, Dilworth GR. The development of green vision in association with terbinafine therapy. Archives of Dermatology. 132: 845-846. DOI: 10.1001/Archderm.1996.03890310137033 |
0.33 |
|
1995 |
Knowles SR, Gutpta AK, Shear NH, Sauder D. Azathioprine hypersensitivity‐like reations–a case report and a review of the literature Clinical and Experimental Dermatology. 20: 353-356. PMID 8549000 DOI: 10.1111/J.1365-2230.1995.Tb01343.X |
0.332 |
|
1995 |
Lanctôt KL, Ghajar BM, Shear NH, Naranjo CA. Improving the diagnosis of hypersensitivity reactions associated with sulfonamides. Journal of Clinical Pharmacology. 34: 1228-33. PMID 7738220 DOI: 10.1002/J.1552-4604.1994.Tb04736.X |
0.342 |
|
1994 |
Gupta AK, Knowles SR, Shear NH. Spironolactone-associated cutaneous effects: a case report and a review of the literature. Dermatology. 189: 402-405. PMID 7873830 DOI: 10.1159/000246889 |
0.324 |
|
1993 |
Gupta AK, Shear NH, Lester RS, Baxter ML, Sauder DN. Betamethasone Dipropionate Polyacrylic Film‐Eorming Lotion In The Treatment Of Hand Dermatitis International Journal of Dermatology. 32: 828-829. PMID 8270348 DOI: 10.1111/J.1365-4362.1993.Tb02778.X |
0.327 |
|
1992 |
Bologa M, Pastuszak A, Shear NH, Koren G. Dermatologic drugs in pregnancy. Clinics in Dermatology. 9: 435-51. PMID 1688017 DOI: 10.1016/0738-081X(91)90072-S |
0.324 |
|
1992 |
Naranjo CA, Shear NH, Lanctôt KL. Advances in the diagnosis of adverse drug reactions. Journal of Clinical Pharmacology. 32: 897-904. PMID 1447396 DOI: 10.1002/J.1552-4604.1992.Tb04635.X |
0.316 |
|
1991 |
Spielberg SP, Shear NH, Cannon M, Hutson NJ, Gunderson K. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil Annals of Internal Medicine. 114: 720-724. PMID 2012352 DOI: 10.7326/0003-4819-114-9-720 |
0.302 |
|
1990 |
Shear NH. Diagnosing cutaneous adverse reactions to drugs. Archives of Dermatology. 126: 94-97. DOI: 10.1001/Archderm.1990.01670250100017 |
0.373 |
|
Show low-probability matches. |